AIM turns 30 today, but birthday celebrations are bound to be overshadowed by swathes of bleak data on the market’s performance. London’s junior stock market has had a woeful period, with projections ...

AIM ImmunoTech Inc. announced that it has received a notice from the NYSE American indicating that it is not in compliance with certain continued listing standards regarding stockholders' equity due ...

Alan Hirzel, Chief Executive Officer of Abcam, said: "This proposed listing change will make it possible for Abcam to attract more investors to our global business. With the change, we see a path to ...

Discover how the Alternative Investment Market helps smaller companies raise capital on the London Stock Exchange with flexible regulations and lower costs.